Spearhead Capital Advisors, LLC Tandem Diabetes Care Inc Transaction History

Spearhead Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$53.22 - $123.09 $116,977 - $270,551	-2,198 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$101.89 - $150.09 $246,879 - $363,668	-2,423 Reduced 52.43%	2,198 $256,000
Q4 2021 Jan 25, 2022	BUY	$118.18 - $153.21 $4,136 - $5,362	35 Added 0.76%	4,621 $696,000
Q3 2021 Oct 27, 2021	SELL	$93.51 - $129.4 $1,496 - $2,070	-16 Reduced 0.35%	4,586 $547,000
Q2 2021 Aug 10, 2021	BUY	$77.0 - $100.19 $43,659 - $56,807	567 Added 14.05%	4,602 $448,000
Q1 2021 Apr 28, 2021	BUY	$81.28 - $104.34 $64,617 - $82,950	795 Added 24.54%	4,035 $356,000
Q4 2020 Feb 02, 2021	BUY	$86.4 - $121.75 $12,700 - $17,897	147 Added 4.75%	3,240 $310,000
Q3 2020 Oct 16, 2020	BUY	$95.43 - $116.09 $17,081 - $20,780	179 Added 6.14%	3,093 $351,000
Q2 2020 Jul 16, 2020	BUY	$60.05 - $98.92 $174,985 - $288,252	2,914 New	2,914 $288,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.